Cambridge Investment Research Advisors, Inc. - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$1,864,000
-52.8%
466,082
-42.2%
0.01%
-60.0%
Q3 2019$3,953,000
-19.6%
806,819
-0.0%
0.04%
-22.2%
Q2 2019$4,915,000
+4.8%
807,019
-0.0%
0.04%0.0%
Q1 2019$4,690,000
-63.9%
807,269
-16.3%
0.04%
-68.8%
Q4 2018$12,983,000
-26.3%
964,592
+6.2%
0.14%
-14.3%
Q3 2018$17,627,000
-24.2%
908,158
-0.2%
0.17%
-31.4%
Q2 2018$23,248,000
+14.9%
909,553
-9.4%
0.24%
+7.5%
Q1 2018$20,232,000
-8.4%
1,004,087
-8.8%
0.23%
-12.3%
Q4 2017$22,098,000
-3.1%
1,101,063
-0.1%
0.26%
-15.0%
Q3 2017$22,816,000
+17.0%
1,101,697
-16.4%
0.31%
+6.6%
Q2 2017$19,496,000
-8.6%
1,317,265
-1.5%
0.29%
-21.2%
Q1 2017$21,326,000
+22.9%
1,337,070
-2.9%
0.36%
+12.0%
Q4 2016$17,350,000
-63.5%
1,376,956
-18.9%
0.32%
-63.2%
Q3 2016$47,536,000
-20.1%
1,697,126
-0.2%
0.88%
-30.0%
Q2 2016$59,504,000
+27.7%
1,700,106
-0.0%
1.26%
+19.7%
Q1 2016$46,598,000
+159.4%
1,700,656
+224.0%
1.05%
+147.8%
Q4 2015$17,961,000
+1178.4%
524,872
+973.1%
0.42%
+962.5%
Q3 2015$1,405,00048,9110.04%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q4 2017
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 7,036,670$42,853,0001.54%
ARMISTICE CAPITAL, LLC 3,200,000$19,488,0001.23%
STEPHENS INC /AR/ 6,600,015$40,194,0000.91%
S&T BANK/PA 610,367$3,718,0000.82%
Rhenman & Partners Asset Management AB 1,203,405$7,329,0000.81%
Matarin Capital Management, LLC 701,445$4,272,0000.30%
Investors Research Corp 89,727$546,0000.28%
Advisory Services Network, LLC 598,802$3,647,0000.22%
FCG ADVISORS, LLC 34,000$207,0000.06%
EVERENCE CAPITAL MANAGEMENT INC 52,730$321,0000.05%
View complete list of DIPLOMAT PHARMACY INC shareholders